Recent insights into the mechanisms of antifungal resistance

Goodman and Gilman's the Pharmacological Basis of Therapeutics

Coon, J. T. (2002) · Focus on Alternative and Complementary Therapies · doi:10.1111/j.2042-7166.2002.tb05480.x · Cited by 1,750 · see citing works

Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · see citing works

Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions

Vermes, A. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.171 · Cited by 803 · see citing works

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical <i>Candida</i> sp. Isolates

Park, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434 · see citing works

<i>TAC1</i> , Transcriptional Activator of <i>CDR</i> Genes, Is a New Transcription Factor Involved in the Regulation of <i>Candida albicans</i> ABC Transporters <i>CDR1</i> and <i>CDR2</i>

Coste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407 · see citing works

<i>Candida albicans</i> Mutations in the Ergosterol Biosynthetic Pathway and Resistance to Several Antifungal Agents

Sanglard, D., Ischer, F., Parkinson, T., Falconer, D., & Bille, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2404-2412.2003 · Cited by 398 · see citing works

A Mutation in Tac1p, a Transcription Factor Regulating <i>CDR1</i> and <i>CDR2</i> , Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in <i>Candida albicans</i>

Coste, A., Turner, V., Ischer, F., Morschhäuser, J., Forche, A., Selmecki, A., Berman, J., Bille, J., & Sanglard, D. (2006) · Genetics · doi:10.1534/genetics.105.054767 · Cited by 385 · see citing works

Resistance to fluconazole and cross‐resistance to amphotericin B in <i>Candida albicans</i> from AIDS patients caused by defective sterol Δ^5,6‐desaturation

Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351 · see citing works

The ATP Binding Cassette Transporter Gene <i>CgCDR1</i> from <i>Candida glabrata</i> Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents

Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A., & Bille, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2753 · Cited by 337 · see citing works

An update on antifungal targets and mechanisms of resistance in<i>Candida</i><i>albicans</i>

Akins, R. A. (2005) · Medical Mycology · doi:10.1080/13693780500138971 · Cited by 291 · see citing works

Azole Resistance in <i>Candida glabrata</i> : Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription Factor

Vermitsky, J.-P., & Edlind, T. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3773-3781.2004 · Cited by 285 · see citing works

Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection

Ruhnke, M., Eigler, A., Tennagen, I., Geiseler, B., Engelmann, E., & Trautmann, M. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.9.2092-2098.1994 · Cited by 250 · see citing works

<i>Candida albicans</i> Zinc Cluster Protein Upc2p Confers Resistance to Antifungal Drugs and Is an Activator of Ergosterol Biosynthetic Genes

MacPherson, S., Akache, B., Weber, S., De Deken, X., Raymond, M., & Turcotte, B. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1745-1752.2005 · Cited by 238 · see citing works

<i>Candida glabrata PDR1</i> , a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants

Tsai, H.-F., Krol, A. A., Sarti, K. E., & Bennett, J. E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1384-1392.2006 · Cited by 237 · see citing works

The genetic basis of fluconazole resistance development in Candida albicans

Morschhäuser, J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00087-x · Cited by 236 · see citing works

Pdr1 regulates multidrug resistance in <i>Candida glabrata</i> : gene disruption and genome‐wide expression studies

Vermitsky, J., Earhart, K. D., Smith, W. L., Homayouni, R., Edlind, T. D., & Rogers, P. D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05235.x · Cited by 233 · see citing works

Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia

Nolte, F. S., Parkinson, T., Falconer, D. J., Dix, S. P., Williams, J. M., Gilmore, C., Geller, R., & Wingard, J. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.196 · Cited by 219 · see citing works

Mechanism of Increased Fluconazole Resistance in <i>Candida glabrata</i> during Prophylaxis

Bennett, J. E., Izumikawa, K., & Marr, K. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1773-1777.2004 · Cited by 217 · see citing works

Role of <i>Candida albicans</i> Transcription Factor Upc2p in Drug Resistance and Sterol Metabolism

Silver, P. M., Oliver, B. G., & White, T. C. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1391-1397.2004 · Cited by 216 · see citing works

Distinct Patterns of Gene Expression Associated with Development of Fluconazole Resistance in Serial <i>Candida albicans</i> Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis

Lopez-Ribot, J. L., McAtee, R. K., Lee, L. N., Kirkpatrick, W. R., White, T. C., Sanglard, D., & Patterson, T. F. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2932 · Cited by 210 · see citing works

Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae.

Agarwal, A. K., Rogers, P. D., Baerson, S. R., Jacob, M. R., Barker, K. S., Cleary, J. D., Walker, L. A., Nagle, D. G., & Clark, A. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306291200 · Cited by 204 · see citing works

Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient

Krogh-Madsen, M., Arendrup, M. C., Heslet, L., & Knudsen, J. D. (2006) · Clinical Infectious Diseases · doi:10.1086/500939 · Cited by 201 · see citing works

Disruption of Ergosterol Biosynthesis Confers Resistance to Amphotericin B inCandida lusitaniae

Young, L. Y., Hull, C. M., & Heitman, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2717-2724.2003 · Cited by 184 · see citing works

A common drug‐responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2 , two genes involved in antifungal drug resistance

de Micheli, M., Billé, J., Schueller, C., & Sanglard, D. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02814.x · Cited by 182 · see citing works

Caspofungin Resistance in<i>Candida albicans</i>: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis

Hernandez, S., López-Ribot, J. L., Najvar, L. K., McCarthy, D. I., Bocanegra, R., & Graybill, J. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1382-1383.2004 · Cited by 162 · see citing works

Molecular Mechanisms of Primary Resistance to Flucytosine in <i>Candida albicans</i>

Hope, W. W., Tabernero, L., Denning, D. W., & Anderson, M. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4377-4386.2004 · Cited by 160 · see citing works

Genome-Wide Expression Profile Analysis Reveals Coordinately Regulated Genes Associated with Stepwise Acquisition of Azole Resistance in Candida albicans Clinical Isolates

Rogers, P. D., & Barker, K. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1220-1227.2003 · Cited by 157 · see citing works

Acquired itraconazole resistance in Aspergillus fumigatus

Dannaoui, É. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.333 · Cited by 145 · see citing works

Overexpression of<i>Candida albicans CDR1</i>,<i>CDR2</i>, or<i>MDR1</i>Does Not Produce Significant Changes in Echinocandin Susceptibility

Niimi, K., Maki, K., Ikeda, F., Holmes, A. R., Lamping, E., Niimi, M., Monk, B. C., & Cannon, R. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1148-1155.2006 · Cited by 134 · see citing works

Clade-Specific Flucytosine Resistance Is Due to a Single Nucleotide Change in the FUR1 Gene of Candida albicans

Dodgson, A. R., Dodgson, K. J., Pujol, C., Pfaller, M. A., & Soll, D. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2223-2227.2004 · Cited by 133 · see citing works

Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans

Barker, K. S. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh336 · Cited by 117 · see citing works

The Candida albicans Cdr2p ATP‐binding cassette (ABC) transporter confers resistance to caspofungin

Schuetzer‐Muehlbauer, M., Willinger, B., Krapf, G., Enzinger, S., Presterl, E., & Kuchler, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03430.x · Cited by 111 · see citing works

Emergence of Resistance to Fluconazole as a Cause of Failure during Treatment of Histoplasmosis in Patients with Acquired Immunodeficiency Disease Syndrome

Wheat, L. J., Connolly, P., Smedema, M. L., Brizendine, E. J., & Hafner, R. (2001) · Clinical Infectious Diseases · doi:10.1086/323781 · Cited by 96 · see citing works

MDR1 -Mediated Drug Resistance in Candida dubliniensis

Wirsching, S., Moran, G. P., Sullivan, D. J., Coleman, D. C., & Morschhäuser, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3416-3421.2001 · Cited by 91 · see citing works

Overexpression of the MDR1 Gene Is Sufficient To Confer Increased Resistance to Toxic Compounds in Candida albicans

Hiller, D., Sanglard, D., & Morschhäuser, J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1365-1371.2006 · Cited by 90 · see citing works

Activation of the Multiple Drug Resistance Gene <i>MDR1</i> in Fluconazole-Resistant, Clinical <i>Candida albicans</i> Strains Is Caused by Mutations in a <i>trans</i> -Regulatory Factor

Wirsching, S., Michel, S., Köhler, G., & Morschhäuser, J. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.2.400-404.2000 · Cited by 88 · see citing works

Multiple Patterns of Resistance to Fluconazole in <i>Candida glabrata</i> Isolates from a Patient with Oropharyngeal Candidiasis Receiving Head and Neck Radiation

Redding, S. W., Kirkpatrick, W. R., Saville, S., Coco, B. J., White, W., Fothergill, A., Rinaldi, M., Eng, T., Patterson, T. F., & Lopez-Ribot, J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.2.619-622.2003 · Cited by 85 · see citing works

Molecular Mechanisms of Fluconazole Resistance in Candida dubliniensis Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis

Perea, S. H., Lopez-Ribot, J. L., Wickes, B. L., Kirkpatrick, W. R., Dib, O. P., Bachmann, S. P., Keller, S. M., Martı́nez, M., & Patterson, T. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1695-1703.2002 · Cited by 80 · see citing works

PDR16‐mediated azole resistance in Candida albicans

Saidane, S., Weber, S., Deken, X. D., St‐Germain, G., & Raymond, M. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05196.x · Cited by 71 · see citing works

Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance

Niimi, M., Niimi, K., Takano, Y., Holmes, A. R., Fischer, F. J., Uehara, Y., & Cannon, R. D. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh456 · Cited by 69 · see citing works

Molecular Mechanisms of Itraconazole Resistance in Candida dubliniensis

Pinjon, E., Moran, G. P., Jackson, C. J., Kelly, S. L., Sanglard, D., Coleman, D. C., & Sullivan, D. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2424-2437.2003 · Cited by 63 · see citing works

Drug-Induced Regulation of the <i>MDR1</i> Promoter in <i>Candida albicans</i>

Harry, J. B., Oliver, B. G., Song, J. L., Silver, P. M., Little, J. T., Choiniere, J., & White, T. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2785-2792.2005 · Cited by 58 · see citing works

Disseminated paracoccidioidomycosis: correlation between clinical and in vitro resistance to ketoconazole and trimethoprim sulphamethoxazole

Hahn, R. C., Conceicao, Y. T. M., Santos, N. L., Ferreira, J. F., & Hamdan, J. S. (2003) · Mycoses · doi:10.1046/j.1439-0507.2003.00901.x · Cited by 58 · see citing works

Proteomic Analysis of Azole Resistance in Candida albicans Clinical Isolates

Hooshdaran, M. Z., Barker, K. S., Hilliard, G. M., Kusch, H., Morschhäuser, J., & Rogers, P. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2733-2735.2004 · Cited by 55 · see citing works

Inactivation of the <i>FCY2</i> Gene Encoding Purine-Cytosine Permease Promotes Cross-Resistance to Flucytosine and Fluconazole in <i>Candida lusitaniae</i>

Chapeland-Leclerc, F., Bouchoux, J., Goumar, A., Chastin, C., Villard, J., & Noël, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3101-3108.2005 · Cited by 48 · see citing works

A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains

Kusch, H., Biswas, K., Schwanfelder, S., Engelmann, S., Rogers, P. D., Hecker, M., & Morschhäuser, J. (2004) · Molecular Genetics and Genomics · doi:10.1007/s00438-004-0984-x · Cited by 44 · see citing works

Multiple cis -Acting Sequences Mediate Upregulation of the MDR1 Efflux Pump in a Fluconazole-Resistant Clinical Candida albicans Isolate

Hiller, D., Stahl, S., & Morschhäuser, J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00196-06 · Cited by 37 · see citing works

Genotypic Evolution of Azole Resistance Mechanisms in Sequential <i>Candida albicans</i> Isolates

Coste, A., Selmecki, A., Forche, A., Diogo, D., Bougnoux, M.-E., d'Enfert, C., Berman, J., & Sanglard, D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00151-07 · Cited by 305 · see citing works

Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Clinically Important Yeast Species

Stevenson, L. G., Drake, S. K., M.S., Y. R. S., Zelazny, A. M., & Murray, P. R. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00687-09 · Cited by 237 · see citing works

Chemical composition, toxicological aspects and antifungal activity of essential oil from Lippia sidoides Cham.

Fontenelle, R. O. S., Morais, S. M., Brito, E. H. S., Kerntopf, M. R., Brilhante, R. S. N., Cordeiro, R. A., Tomé, A. R., Queiroz, M. G. R., Nascimento, N. R. F., Sidrim, J. J. C., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm066 · Cited by 181 · see citing works

Synthesized zinc peroxide nanoparticles (ZnO2-NPs): a novel antimicrobial, anti-elastase, anti-keratinase, and anti-inflammatory approach toward polymicrobial burn wounds

Ali, S. S., Morsy, R., El-Zawawy, N. A., Fareed, M. F., & Bedaiwy, M. Y. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s141201 · Cited by 149 · see citing works

Targeting the Fungal Cell Wall: Current Therapies and Implications for Development of Alternative Antifungal Agents

Hasim, S., & Coleman, J. J. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0465 · Cited by 144 · see citing works

Modes of Action of the New Arylguanidine Abafungin beyond Interference with Ergosterol Biosynthesis and in vitro Activity against Medically Important Fungi

Borelli, C., Schaller, M., Niewerth, M., Nocker, K., Baasner, B., Berg, D., Tiemann, R., Tietjen, K., Fugmann, B., Lang‐Fugmann, S., et al. (2008) · Chemotherapy · doi:10.1159/000142334 · Cited by 132 · see citing works

Antifungal agents commonly used in the superficial and mucosal candidiasis treatment: mode of action and resistance development

Bondaryk, M., Kurzątkowski, W., & Staniszewska, M. (2013) · Advances in Dermatology and Allergology · doi:10.5114/pdia.2013.38358 · Cited by 126 · see citing works

In vitro antifungal, anti-elastase and anti-keratinase activity of essential oils of Cinnamomum-, Syzygium- and Cymbopogon-species against Aspergillus fumigatus and Trichophyton rubrum

Khan, M. S., & Ahmad, I. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.07.005 · Cited by 124 · see citing works

Antifungal activity of thiosemicarbazones, bis(thiosemicarbazones), and their metal complexes

Bajaj, K., Buchanan, R. M., & Grapperhaus, C. A. (2021) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2021.111620 · Cited by 122 · see citing works

Inhibition of Fungal and Bacterial Plant Pathogens In Vitro and In Planta with Ultrashort Cationic Lipopeptides

Makovitzki, A., Viterbo, A., Brotman, Y., Chet, I., & Shai, Y. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01334-07 · Cited by 114 · see citing works

Identification and Mode of Action of a Plant Natural Product Targeting Human Fungal Pathogens

Dorsaz, S., Snäkä, T., Favre-Godal, Q., Maudens, P., Boulens, N., Furrer, P., Ebrahimi, S. N., Hamburger, M. O., Allémann, É., Gindro, K., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00829-17 · Cited by 93 · see citing works

Functional Analysis of <i>cis</i> - and <i>trans</i> -Acting Elements of the <i>Candida albicans CDR2</i> Promoter with a Novel Promoter Reporter System

Coste, A. T., Crittin, J., Bauser, C., Rohde, B., & Sanglard, D. (2009) · Eukaryotic Cell · doi:10.1128/ec.00069-09 · Cited by 79 · see citing works

Antifungal activity of four honeys of different types from Algeria against pathogenic yeast: Candida albicans and Rhodotorula sp.

Ahmed, M., Djebli, N., Aissat, S., Abdelmelek, M., & Abdelkader, B. (2012) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(12)60096-3 · Cited by 78 · see citing works

Ultraviolet‐C Light for Treatment ofCandida albicansBurn Infection in Mice

Dai, T., Kharkwal, G. B., Zhao, J., Denis, T. G. S., Wu, Q., Xia, Y., Huang, L., Sharma, S. K., d’Enfert, C., & Hamblin, M. R. (2011) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2011.00886.x · Cited by 65 · see citing works

Exposure of Candida albicans β (1,3)-glucan is promoted by activation of the Cek1 pathway

Chen, T., Jackson, J. W., Tams, R. N., Davis, S. E., Sparer, T. E., & Reynolds, T. B. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1007892 · Cited by 56 · see citing works

2‐hydroxyisocaproic acid is fungicidal for Candida and Aspergillus species

Sakko, M., Moore, C. B., Frazer, L. N., Rautemaa, V., Sorsa, T. A., Hietala, P. K., Järvinen, A., Bowyer, P., Tjäderhane, L., & Rautemaa‐Richardson, R. (2013) · Mycoses · doi:10.1111/myc.12145 · Cited by 56 · see citing works

Identification and Functional Characterization of Rca1, a Transcription Factor Involved in both Antifungal Susceptibility and Host Response in Candida albicans

Vandeputte, P., Pradervand, S., Ischer, F., Coste, A. T., Ferrari, S., Harshman, K., & Sanglard, D. (2012) · Eukaryotic Cell · doi:10.1128/ec.00134-12 · Cited by 51 · see citing works

Nonsense and Missense Mutations in FCY2 and FCY1 Genes Are Responsible for Flucytosine Resistance and Flucytosine-Fluconazole Cross-Resistance in Clinical Isolates of Candida lusitaniae

Florent, M., Noël, T., Ruprich‐Robert, G., Silva, B. D., Fitton‐Ouhabi, V., Chastin, C., Papon, N., & Chapeland‐Leclerc, F. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00880-08 · Cited by 50 · see citing works

Two small, cysteine-rich and cationic antifungal proteins from Penicillium chrysogenum: A comparative study of PAF and PAFB

Huber, A. L., Galgóczy, L., Váradi, G., Holzknecht, J., Kakar, A., Malanović, N., Leber, R., Koch, J. M., Keller, M. A., Batta, G., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183246 · Cited by 49 · see citing works

Antifungal Activity of Leaf Essential Oil and Extracts of Metasequoia glyptostroboides Miki ex Hu

Bajpai, V. K., & Kang, S. C. (2009) · Journal of the American Oil Chemists Society · doi:10.1007/s11746-009-1500-6 · Cited by 48 · see citing works

Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species

Silva, D. B. D. S., Rodrigues, L. M. C., Almeida, A. A. D., Oliveira, K. M. P. D., & Grisolia/, A. B. (2016) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760150400 · Cited by 42 · see citing works

The small molecular mass antifungal protein of Penicillium chrysogenum – a mechanism of action oriented review

Hegedüs, N., Leiter, É., Kovács, B., Tomori, V., Kwon, N., Emri, T., Marx, F., Batta, G., Csernoch, L. J., Haas, H., et al. (2011) · Journal of Basic Microbiology · doi:10.1002/jobm.201100041 · Cited by 39 · see citing works

Plant-Derived Substances in the Fight Against Infections Caused by Candida Species

Guevara-Lora, I., Braś, G., Karkowska‐Kuleta, J., Gonzalez‐Gonzalez, M., Ceballos, K., Sidlo, W., & Rąpała‐Kozik, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176131 · Cited by 38 · see citing works

RNA sequencing revealed novel actors of the acquisition of drug resistance in Candida albicans

Dhamgaye, S., Bernard, M., Lelandais, G., Sismeiro, O., Lemoine, S., Coppée, J., Crom, S. L., Prasad, R., & Devaux, F. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-396 · Cited by 36 · see citing works

Carum copticum and Thymus vulgaris oils inhibit virulence in Trichophyton rubrum and Aspergillus spp

Khan, M. S., Ahmad, I., & Cameotra, S. S. (2014) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822014000200021 · Cited by 29 · see citing works

Chemical Composition of Celandine (Chelidonium majus L.) Extract and its Effects on Botrytis tulipae (Lib.) Lind Fungus and the Tulip

Pârvu, M., Vlase, L., Fodorpataki, L., PARVU, O., Roşca-Casian, O., Bartha, C., Barbu–Tudoran, L., & Pârvu, A. E. (2013) · Notulae Botanicae Horti Agrobotanici Cluj-Napoca · doi:10.15835/nbha4129077 · Cited by 26 · see citing works

A Mini Review of Candida Species in Hospital Infection: Epidemiology,Virulence Factor and Drugs Resistance and Prophylaxis

Pitangui, N. D. S. (2013) · Tropical Medicine & Surgery · doi:10.4172/2329-9088.1000141 · Cited by 26 · see citing works

Ruta montana L. leaf essential oil and extracts

Hammami, I., Smaoui, S., Hsouna, A. B., Hamdi, N., & Triki, M. A. (2015) · EXCLI journal · doi:10.17179/excli2014-655 · Cited by 23 · see citing works

Changes in Botrytis cinerea Conidia Caused by Berberis vulgaris Extract

Pârvu, M., Pârvu, A. E., Crăciun, C., Barbu–Tudoran, L., Vlase, L., Tămaş, M., Roşca-Casian, O., Persecă, O., & Molnar, A. (2010) · Notulae Botanicae Horti Agrobotanici Cluj-Napoca · doi:10.15835/nbha3834741 · Cited by 21 · see citing works

Commercially available lipid formulations of amphotericin b: are they bioequivalent and therapeutically equivalent?

Cifani, C., Costantino, S., Massi, M., & Berrino, L. (2012) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 18 · see citing works

Evaluación de la espectrometría de masas en la identificación de levaduras de interés clínico

Galán‐Sánchez, F., García-Agudo, L., Guerrero, I., Marín, P., García-Tapia, A. M., García-Martos, P., & Rodríguez‐Iglesias, M. (2014) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2014.10.003 · Cited by 18 · see citing works

Antifungal activity ofPterocaulon alopecuroides(Asteraceae) against chromoblastomycosis agents

Daboit, T. C., Stopiglia, C. D. O., von Poser, G. L., & Scroferneker, M. L. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01704.x · Cited by 14 · see citing works

Functional characterization of the hexose transporter Hxt13p: An efflux pump that mediates resistance to miltefosine in yeast

Biswas, C., Djordjevic, J. T., Zuo, X., Boles, E., Jolliffe, K. A., Sorrell, T. C., & Chen, S. C.-A. (2013) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2013.09.005 · Cited by 13 · see citing works

In-Vitro Study Of Antifungal Activity Of Various Commercially Available Itra (Volatile Plant Oil) Against The Keratinophilic Fungi Isolated From Soil

Dwivedi, P. S. R. B. A. L. (2011) · Cited by 12 · see citing works

Chemical Composition of the Leaf Oil ofCymbopogon martiniivar.sofiaCollected from Udaipur, Rajasthan and their Screening Against Fungi Causing Dermatophytosis in Human Beings

Jain, N., & Sharma, M. (2017) · Journal of Essential Oil Bearing Plants · doi:10.1080/0972060x.2017.1341344 · Cited by 11 · see citing works

Known Antimicrobials Versus Nortriptyline in Candida albicans: Repositioning an Old Drug for New Targets

Caldara, M., & Marmiroli, N. (2020) · Microorganisms · doi:10.3390/microorganisms8050742 · Cited by 8 · see citing works

Screening of selected medicinal plants for in vitro antidermatophytic activity

Kalaivanan, C., Chandrasekaran, M., & Venkatesalu, V. (2013) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2013.09.004 · Cited by 8 · see citing works

Molecular Methods Developed for the Identification and Characterization of Candida Species

Grisolia, A. (2017) · International Journal of Genetic Science · doi:10.15226/2377-4274/4/1/00114 · Cited by 7 · see citing works

Subinhibitory concentrations of fluconazole increase the intracellular sodium content in both fluconazole-resistant and -sensitive Candida albicans strains

Kolecka, A., Krauke, Y., Bujdáková, H., & Sychrová, H. (2009) · Canadian Journal of Microbiology · doi:10.1139/w09-009 · Cited by 6 · see citing works

Therapeutic drug monitoring for antifungal triazoles: pharmacologic background and current status

Groll, A. H., & Gastine, S. (2019) · Handbook of analytical separations · doi:10.1016/b978-0-444-64066-6.00009-5 · Cited by 6 · see citing works

In vitrofungitoxic and cytotoxic efficacy ofChloroxylon swieteniaDC. leaf essential oil

Senthilkumar, A., & Venkatesalu, V. (2013) · Journal of Essential Oil Research · doi:10.1080/10412905.2013.782472 · Cited by 2 · see citing works

Studies on Elastase and Elastase Inhibitor from Aspergillus flavus

Nikai, T. (2021) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.20-00193 · Cited by 2 · see citing works

Rapid Identification of Clinical Yeast Isolates by Mass Spectrometry

Murray, P. R. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0019-5 · Cited by 2 · see citing works

Biochemical and cellular activity of chemically synthesized elastase inhibitor (S-AFUEI) from Aspergillus fumigatus

Fukui, Y., Okumura, Y., Uchiya, K., Komori, Y., Ogawa, K., Nikai, T., & Hasegawa, Y. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.05.001 · Cited by 2 · see citing works

Fungal Infections in Humans

Jain, N., & Fries, B. C. (2011) · Wiley eBooks · doi:10.1002/9780470015902.a0002234.pub2 · Cited by 2 · see citing works

Résistance des Candida aux antifongiques : détection et mécanismes

Dannaoui, É. (2013) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(13)71948-8 · Cited by 1 · see citing works

ITS and pB2.5 gene expression of Naegleria fowleri in drug resistance

Rabablert, J., Tiewcharoen, S., & Junnu, V. (2011) · Health · doi:10.4236/health.2011.38088

Genetic determinants of antifungal resistance in Candida species

Silva, D. B. D. S., Barufatti, A., & Kelly, M. P. D. O. (2016) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb2016.15295

Assessment of Azole Resistance in Healthcare Facilities

Caetano, L. A., Costa, N. A., & Oliveira, C. V. D. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.21351-4

Characterization of ZCF Transcription Factors That Are Expanded in the Human Pathogen Candida albicans

Japutra, C. (2014) · Digital WPI

Antifungal activity of raw honey collected from Apis dorsata Fabricius Honeybee

Ansari, H., Agnihotri, M., Khan, M. S., Baweja, H. S., & Khan, A. A. (2024) · International Journal of Advanced Biochemistry Research · doi:10.33545/26174693.2024.v8.i1e.378

Antifungal Agents

Groll, A. H., & Walsh, T. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00256-9

Ação in vitro de extratos de Arrabidaea chica sobre Candida albicans

Berla, S. M. C., Damasceno, A. P. L. G., Leão, M. V. P., & dos Santos, S. S. F. (2020) · Revista Brasileira de Plantas Medicinais · doi:10.70151/wsdqp791

Métabolisme des glycannes pariétaux impliqués dans les relations hôte-pathogène : étude sur les genres Candida et Mycobacterium

Méry, A. (2019) · theses.fr (ABES) · doi:10.70675/a79bfd37z5e4cz411dza4b9zefed3a87065f

Multiple resistance mechanisms to azole antifungals in yeast clinical isolates

Sanglard, D., Ischer, F., Calabrese, D. R., de Micheli, M., & Billé, J. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80006-x · Cited by 97 · see citing works

Antifungal drug resistance mechanisms

Pemán, J., Cantón, E., & Espinel‐Ingroff, A. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.18 · Cited by 121 · see citing works

Advances in the study of the mechanism of Candida's drug resistance

Bi, W. (2014) · Journal of Pathogen Biology

Understanding the mechanisms of resistance to azole antifungals in Candida species

Li, Y., Hind, C. K., Furner-Pardoe, J., Sutton, J. M., & Rahman, K. M. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf106 · Cited by 67 · see citing works

Molecular mechanisms of drug resistance in fungi

BOSSCHE, H. V., Marichal, P., & Odds, F. C. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90618-1 · Cited by 255 · see citing works